{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:05:57Z","timestamp":1787785557483,"version":"build-2784847793"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241178-4\"><jats:title>Importance<\/jats:title><jats:p>The association between radiotherapy (RT) timing after radical prostatectomy and long-term patient-reported health-related quality of life (HRQOL) in men with prostate cancer is unknown.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241178-5\"><jats:title>Objective<\/jats:title><jats:p>To measure long-term HRQOL in men with prostate cancer up to 15 years after prostatectomy with or without RT and examine whether early vs late postprostatectomy RT is associated with differences in sexual, urinary, and bowel HRQOL.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241178-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>A prospective, multicenter, longitudinal cohort analysis using HRQOL data from the PROST-QA (2003-2006) and RP2 consortium (2010-2013) studies was conducted. Men with localized prostate cancer undergoing radical prostatectomy were included. Data were analyzed between May 8, 2023, and March 1, 2024. The study was conducted in 12 high-volume academic medical centers in the US.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241178-7\"><jats:title>Exposures<\/jats:title><jats:p>Men were stratified based on receipt and timing of postprostatectomy RT: prostatectomy only, early RT (&amp;amp;lt;12 months), and late RT (\u226512 months).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241178-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Longitudinal sexual, incontinence, urinary irritation, bowel, and hormonal\/vitality HRQOL were measured via the Expanded Prostate Cancer Index Composite at baseline; months 2, 6, and 12; and annually thereafter. Treatment groups were compared using multivariable linear mixed-effects models of change in longitudinal domain scores. Pad use for incontinence was measured longitudinally among men receiving postprostatectomy RT.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241178-9\"><jats:title>Results<\/jats:title><jats:p>A total of 1203 men were included in the study: prostatectomy only (n\u2009=\u20091082), early RT (n\u2009=\u200957), and late RT (n\u2009=\u200964). Median age for the entire cohort was 60.5 (range, 38.8-79.7) years, and 1075 men (92.0%) were White. Median follow-up was 85.6 (IQR, 35.8-117.2) months. Compared with men receiving prostatectomy alone, those receiving postprostatectomy RT had significantly greater decreases in sexual, incontinence, and urinary irritation HRQOL. However, timing of postprostatectomy RT, specifically early vs late, was not associated with a long-term decrease in any HRQOL domain. There was evidence of improved recovery of sexual, continence, and urinary irritation scores among men receiving early RT compared with those receiving late RT after prostatectomy. Before the start of postprostatectomy RT, 39.3% of men in the early RT cohort and 73.4% of men in the late RT cohort were pad-free. By the sixth visit post-RT, 67.4% in the early RT cohort and 47.6% in the late RT cohort were pad-free.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241178-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this multicenter, prospective analysis, postprostatectomy RT appeared to be negatively associated with long-term HRQOL across all domains. However, receipt of early vs late postprostatectomy RT may result in similar long-term HRQOL outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.40747","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:32:05Z","timestamp":1729783925000},"page":"e2440747","source":"Crossref","is-referenced-by-count":6,"title":["Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life"],"prefix":"10.1001","volume":"7","author":[{"given":"Sagar A.","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"},{"name":"Department of Urology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dattatraya","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Urology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Urology, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Saigal","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Litwin","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Klein","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald L.","family":"Andriole","sequence":"additional","affiliation":[{"name":"Department of Urology, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misop","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Urology, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Michalski","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Urology, Beaumont Health, Royal Oak, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Hembroff","sequence":"additional","affiliation":[{"name":"Office of Survey Research, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Sandler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Hamstra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Pisters","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Kuban","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith M.","family":"Regan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina M.","family":"Crociani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Sanda","sequence":"additional","affiliation":[{"name":"Department of Urology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PROST-QA\/RP2 Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Dunn","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Northouse","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Greenfield","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Ciezki","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Dahl","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Zietman","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Feng","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Skolarus","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Davis","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Stork","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Mahadevan","sequence":"additional","affiliation":[{"name":"for the PROST-QA\/RP2 Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"7","key":"zoi241178r1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.2018.19941","article-title":"Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015.","volume":"321","author":"Mahal","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi241178r2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1464-410X.2011.10422.x","article-title":"The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.","volume":"109","author":"Antonarakis","year":"2012","journal-title":"BJU Int"},{"issue":"9858","key":"zoi241178r3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"zoi241178r4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"issue":"2","key":"zoi241178r5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial.","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur Urol"},{"issue":"10","key":"zoi241178r6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10","key":"zoi241178r7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10260","key":"zoi241178r8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"issue":"10260","key":"zoi241178r9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","article-title":"Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.","volume":"396","author":"Vale","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"zoi241178r10","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1200\/JCO.20.03714","article-title":"Adjuvant versus early salvage radiation therapy for men at high risk for recurrence following radical prostatectomy for prostate cancer and the risk of death.","volume":"39","author":"Tilki","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi241178r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5230","article-title":"Comparison between adjuvant and early-salvage postprostatectomy radiotherapy for prostate cancer with adverse pathological features.","volume":"4","author":"Hwang","year":"2018","journal-title":"JAMA Oncol"},{"issue":"12","key":"zoi241178r12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors.","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi241178r13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"issue":"6","key":"zoi241178r14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"issue":"12","key":"zoi241178r15","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","article-title":"Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.","volume":"23","author":"Miller","year":"2005","journal-title":"J Clin Oncol"},{"key":"zoi241178r16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0149-7189(89)90038-4","article-title":"Steps towards a multifactorial satisfaction scale for primary care and mental health services.","volume":"12","author":"Greenfield","year":"1989","journal-title":"Eval Program Plann"},{"issue":"5","key":"zoi241178r17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"5","key":"zoi241178r18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.eururo.2017.01.039","article-title":"Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients.","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"zoi241178r19","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1016\/j.clgc.2019.09.007","article-title":"Impact of adherence to multidisciplinary recommendations for adjuvant treatment in radical prostatectomy patients with high risk of recurrence.","volume":"18","author":"Knipper","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"zoi241178r20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.radonc.2019.12.006","article-title":"Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): a randomised trial.","volume":"145","author":"Murthy","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"zoi241178r21","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"zoi241178r22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2012.10.012","article-title":"Centralization of radical prostatectomy in the United States.","volume":"189","author":"Anderson","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"zoi241178r23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.juro.2012.10.028","article-title":"Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.","volume":"189","author":"Sammon","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"zoi241178r24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.eururo.2013.04.012","article-title":"A systematic review of the volume-outcome relationship for radical prostatectomy.","volume":"64","author":"Trinh","year":"2013","journal-title":"Eur Urol"},{"issue":"8","key":"zoi241178r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27637","article-title":"Radiation facility volume and survival for men with very high-risk prostate cancer treated with radiation and androgen deprivation therapy.","volume":"6","author":"Sebastian","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi241178r26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ijrobp.2015.12.008","article-title":"Association between treatment at a high-volume facility and improved survival for radiation-treated men with high-risk prostate cancer.","volume":"94","author":"Chen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2825301\/patel_2024_oi_241178_1729184109.81898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:32:07Z","timestamp":1729783927000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2825301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.40747","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}